Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes

Protein Science

Volumn 7, Issue 4, 1998, Pages 815-836

  Khan, Amir R ^a   James, Michael N G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Conversion; Limited proteolysis; Prosegment; Proteinase; Zymogen

Indexed keywords

ASPARTIC PROTEINASE; CYSTEINE PROTEINASE; ENZYME PRECURSOR; PROTEINASE; SERINE PROTEINASE; STROMELYSIN;

AMINO TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; ENZYME ACTIVATION; ENZYME STABILITY; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; ENZYME SYNTHESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; REVIEW; X RAY CRYSTALLOGRAPHY;

EID: 0031956497     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560070401     Document Type: Review

References (182)

1. Allaire M, Chernaia M, Malcolm BA, James MNG. 1994. Picornaviral 3C cysteine proteinases have a fold similar to the chymotrypsin-like serine proteinases. Nature (London) 369:72-77.
2. Auer HE, Glick DM. 1984. Early events of pepsinogen activation. Biochemistry 23:2735-2739.
3. Aviles FX, Vendrell J, Guasch A, Coll M, Huber R. 1993. Advances in metalloprocarboxypeptidases. Emerging details on the inhibition mechanism and on the activation process. Eur J Biochem 211:381-389.
4. Baker D, Shiau AK, Agard DA. 1993. The role of pro regions in protein folding. Curr Op Cell Biol 5:966-970.
5. Baker D, Sohl JL, Agard DA. 1992. A protein-folding reaction under kinetic control. Nature 356:263-265.
6. Baker EN, Drenth J. 1987. The thiol proteases: Structure and mechanism. In: Jurnak FA, McPherson A, eds. Biological macromolecules and assemblies, Vol. 3. New York: John Wiley and Sons. pp 313-368.
7. Bartunik HD, Summers LJ, Bartsch HH. 1989. Crystal structure of bovine β-trypsin in a crystal form with low molecular packing density. Active site geometry, ion pairs and solvent structure. J Mol Biol 210:813-828.
8. Bateman KS, Cherney MM, Tarasova NI, James MNG. 1998. Crystal structure of human pepsinogen A. In: James MNG, ed. The aspartic proteinases: Retroviral, fungal, plant and mammalian. New York: Plenum Press. In press.
9. Baudys M, Kostka V. 1983. Covalent structure of chicken pepsinogen. Eur J Biochem 136:89-99.
10. Becker JW, Marcy AI, Rokosz LL, Axel MG, Burbaum JJ, Fitzgerald PMD, Cameron PM, Esser CK, Hagmann WK, Hermies JD, Springer JP. 1995. Stromelysin-1: Three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Protein Sci 4:1966-1976.
11. Berti PJ, Storer AC. 1995. Alignment/phylogeny of the papain superfamily of cysteine proteases. J Mol Biol 246:273-283.
12. Birkedal-Hansen H, Werb Z, Welgus H, Van Wart H. 1990. In: James MNG, ed. Matrix metalloproteinases and inhibitors. Stuttgart, Germany: Gustav Fischer Verlag.
13. Blevins RA, Tulinsky A. 1985. The refinement and the structure of the dimer of α-chymotrypsin at 1.67 Å resolution. J Biol Chem 260:4624-4275.
14. Blundell TL, Johnson MS. 1993. Catching a common fold. Protein Sci 2:877-883.
15. Bode W. 1979. The transition of trypsinogen to a trypsin-like state upon strong ligand binding. II. The binding of pancreatic trypsin inhibitor and of isoleucine-valine and of sequentially related peptides to trypsinogen and to p-guanidinobenzoate-trypsinogen. J Mol Biol 127:357-374.
16. Bode W, Engh R, Musi D, Thiele U, Huber R, Karshikov A, Brzin J, Kos J, Turk V. 1988. The 2.0 Å X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J 7:2593-2599.
17. Bode W, Huber R. 1978. Crystal structure analysis and refinement of two variants of trigonal trypsinogen. FEBS Lett 90:265-269.
18. Bode W, Huber R. 1992. Natural protein proteinase inhibitors and their interaction with proteinases. Eur J Biochem 204:433-451.
19. Bode W, Renatus M. 1997. Tissue-type plasminogen activator: Variants and crystal/solution structures demarcate structural determinants of function. Curr Op Struct Biol 7:865-872.
20. Bode W, Schwager P. 1975. The refined crystal structure of bovine β-trypsin at 1.8 Å resolution. II. Crystallographic refinement, calcium binding site and active site at pH 7.0. J Mol Biol 98:693-717.
21. Bode W, Schwager P, Huber R. 1976. In: Ribbons DW, Brew W, eds. Proteolysis and physiological regulation. Miami Winter Symposia, Vol. 11. New York: Academic Press, pp 43-76.
22. Bode W, Schwager P, Huber R. 1978. The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. The refined crystal structures of the bovine trypsinogen-pancreatic trypsin inhibitor complex and of its ternary complex with ILE-Val at 1.9 Å resolution. J Mol Biol 118:99-112.
23. Bolognesi M, Gatti G, Menegatti E, Guarneri M, Marquart M, Papamokos E, Huber R. 1982. Three-dimensional structure of the complex between pancreatic secretory trypsin inhibitor (Kazal type) and trypsinogen at 1.8 Å resolution. J Mol Biol 162:839-868.
24. Bond JS, Beyon RJ. 1995. The astacin family of metalloendopeptidases. Protein Sci 4:1247-1261.
25. Bonten EJ, Galjart NJ, Willemsen R, Usmany M, Vlak JM, d'Azzo A. 1995. Lysosomal protective protein/cathepsinA: Role of the 'linker' domain in catalytic activation. J Biol Chem 270:26441-26445.
26. Brannigan JA, Dodson G, Duggleby HJ, Moody PC, Smith JL, Tomchick DR, Murzin AG. 1995. A protein catalytic framework with an N-terminal nucleophile is capable of self-activation. Nature 378:416-419.
27. Brayer GD, Delbaere LT, James MNG. 1979. Molecular structure of the α-lytic protease from Myxobacter 495 at 2.8 Å resolution. J Mol Biol 131:743-775.
28. Brenner S. 1988. The molecular evolution of genes and proteins: A tale of two serines. Nature 334:528-530.
29. Bryan P, Wang L, Hoskins J, Ruvinov S, Strausberg S, Alexander P, Almog O, Gilliland G, Gallagher T. 1995. Catalysis of a protein folding reaction: Mechanistic implications of the 2.0 Å structure of the subtilisin-prodomain complex. Biochemistry 34:10310-10318.
30. Burgos FJ, Pascual R, Salva M, Cuchillo CM, Aviles FX. 1989. The separation of pancreatic procarboxypeptidases by high-performance liquid chromatography and chromatofocusing. J Chromatogr 481:233-243.
31. Burgos FJ, Salva M, Villegas V, Soriano F, Mendez E, Aviles FX. 1991. Analysis of the activation process of porcine procarboxypeptidase B and determination of the sequence of its activation segment. Biochemistry 30:4082-4089.
32. Carmona E, Dufour E, Plouffe C, Takebe S, Mason P, Mort JS, Menard R. 1996. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases. Biochemistry 35:8149-8157.
33. Chen P, Hochstrasser M. 1996. Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly. Cell 86:961-972.
34. Christianson DW, Lipscomb WN. 1989. Carboxypeptidase A. Acc Chem Res 22:62-69.
35. Ciechanover A. 1994. The ubiquitin-proteasome proteolytic pathway. Cell 79: 13-21.
36. Cohen GH, Silverton EW, Davies DR. 1981. Refined crystal structure of γ-chymotrypsin at 1.9 Å resolution. Comparison with other pancreatic serine proteases. J Mol Biol 148:449-479.
37. Coll M, Guasch A, Aviles FX, Huber R. 1991. Three-dimensional structure of porcine procarboxypeptidase B: Structural basis of its inactivity. EMBO J 10:1-9.
38. Coulombe R, Grochulski P, Sivaraman J, Menard R, Mort JS, Cygler M. 1996. Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J 15:5492-5503.
39. Craik CS, Roczniak S, Largman C, Rutter WJ. 1987. The catalytic role of the active site aspartic acid in serine proteases. Science 239:909-913.
40. Cuozzo JW, Tao K, Wu Q, Yong W, Sahagian GG. 1995. Lysine-based structure in the proregion of procathepsin L is the recognition site for mannose phosphorylation. J Biol Chem 270:15611-15619.
41. Cutfield SM, Dodson EJ, Anderson BF, Moody PC, Marshall CJ, Sullivan PA, Cutfield JF. 1995. The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors. Structure 3:1261-1271.
42. Cygler M, Sivaraman J, Grochulski P, Coulombe R, Storer AC, Mort JS. 1996. Structure of rat procathepsin B. Model for inhibition of cysteine protease activity by the proregion. Structure 4:405-416.
43. Davie EW, Fujikawa K, Kisiel W. 1991. The coagulation cascade: Initiation, maintenance and regulation. Biochemistry 30:10363-10370.
44. Davie EW, Neurath H. 1955. Identification of a peptide released during autocatalytic activation of trypsinogen. J Biol Chem 212:515-529.
45. Davies DR. 1990. The structure and function of the aspartic proteinases. Ann Rev Bioph Chem 19:189-215.
46. d'Azzo A, Hoogeveen A, Reuser AJJ, Robinson D, Galjaard H. 1982. Molecular delect in combined β-galactosidase and neuraminidase deficiency in man. Proc Nat Acad Sci (USA) 79:4535-4539.
47. Desnuelle P. 1959. In: Boyer RD, Lardy H, Myrback K, eds. The enzymes, Vol. 4. New York: Academic Press. pp 93-118.
48. Docherty AJP, O'Connell J, Crabbe T, Angal S, Murphy G. 1992. The matrix metalloproteinases and their natural inhibitors - Prospects for treating degenerative tissue diseases. Trends Biotechnol 10:200-207.
49. Dunn B. 1997. Splitting image. Nature Struct Biol 4:969-972.
50. Endrizzi JA, Breddam K, Remington SJ. 1994. 2.8 Å-structure of yeast carboxypeptidase. Biochemistry 33:11106-11120.
51. Esnouf RM. 1997. An extensively modified version of MolScript that includes greatly enhanced colouring capabilities. J Mol Graphics 15:133-138.
52. Fehlhammer H, Bode W, Huber R. 1977. Crystal structure of bovine trypsinogen at 1.8 Å resolution. II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin. J Mol Biol 111:415-438.
53. Folk JE. 1956. A new pancreatic carboxypeptidase. J Am Chem Soc 78:3541-3542.
54. Foltmann B. 1988. Aspartic proteinases: Alignment of amino acid sequences. In: Foltmann B, ed. Proceedings of the 18th Linderstrom-Lang Conference, 4-8 July 1988. Elsinore, Denmark, pp 7-20.
55. Foltmann B, Jensen AL. 1982. Human progastricsin. Analysis of intermediates during activation into gastricsin and determination of the amino acid sequence of the propart. Eur J Biochem 128:63-70.
56. Francis SE, Banerjee R, Goldberg DE. 1997. Biosynthesis and maturation of the malarial aspartic hemoglobinases plasmepsins I and II. J Biol Chem 272:14961-14968.
57. Freer ST, Kraut J, Robertus JD, Wright HT, Xuong NH. 1970. Chymotrypsinogen: 2.5 Å crystal structure, comparison with α-chymotrypsin, and implications for zymogen activation. Biochemistry 9:1997-2009.
58. Galjart NJ, Moreau H, Willemsen R, Gillemans N, Bonten EJ, d'Azzo A. 1991. Human lysosomal protective protein has a cathepsin A-like activity distinct from its protective function. J Biol Chem 266:14754-14762.
59. Gallagher T, Gilliland G, Wang L, Bryan P. 1995. The prosegment BPN′ complex: Crystal structure of a specific foldase. Structure 3:907-914.
60. Garcia-Saez I, Reverter D, Vendrell J, Aviles FX, Coll M. The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of the inhibition, activation and intrinsic activity of the zymogen. EMBO J 16:6906-6913.
61. Glick DM, Shalitin Y, Hitt CR. 1989. Studies of the irreversible step of pepsinogen activation. Biochemistry 28:2626-2630.
62. Gomes-Ruth FX, Gomez-Ortiz M, Vendrell J, Ventura S, Bode W, Huber R, Aviles FX. 1997. Crystal structure of an oligomer of proteolytic zymogens: Detailed conformational analysis of the bovine ternary complex and implications for their activation. J Mol Biol 269:861-880.
63. Greenberg AH. 1996. Granzyme B-induced apoptosis. Adv Exp Med & Biol 406:219-228.
64. Groettrup M, Soza A, Jucjelkorn U, Kloetzel PM. 1996. Peptide antigen production by the proteasome: Complexity provides efficiency. Immunology Today 17:429-435.
65. Groll M, Ditzel L, Lowe W, Stock D, Bochtler M, Bartunik HD, Huber R. 1997. Structure of the 20S proteasome from yeast at 2.4 Å resolution. Nature 386:463-471.
66. Groves MR, Taylor MAJ, Scott M, Cummings NJ, Pickersgill RW, Jenkins JA. 1996. The prosequence of procaricain forms an α-helical domain that prevents access to the substrate-binding cleft. Structure 4:1193-1203.
67. Guasch A, Coll M, Aviles FX, Huber R. 1992. Three-dimensional structure of porcine pancreatic procarboxypeptidase A. A comparison of the A and B zymogens and their determinants for inhibition and activation. J Mol Biol 224:141-157.
68. Hanson JE, Kaplan AP, Bartlett PA. 1989. Phosphonate analogues of carboxypeptidase A substrates are potent transition-state analogue inhibitors. Biochemistry 28:6294-6305.
69. Hartsuck JA, Koelsch G, Remington SJ. 1992. The high-resolution structure of porcine pepsinogen. Proteins Struct Funct Genet 13:1-25.
70. Hayano T, Sogawa K, Ichihara Y, Fuji-Kuriyama Y, Takahashi K. 1988. Primary structure of human pepsinogen C gene. J Biol Chem 263:1382-1385.
71. Herriott RM. 1939. Kinetics of the formation of pepsin from swine pepsinogen and identification of an intermediate compound. J Gen Physiol 22:65-78.
72. Hofmann T. 1989. Zoological research. Beijing (in Chinese).
73. Huber R, Bode W. 1978. Structural basis of the activation and action of trypsin. Acc Chem Res 11:114-122.
74. Ichihara Y, Sogawa K, Morohashi K, Fuji-Kuriyama Y, Takahashi K. 1986. Nucleotide sequence of a nearly full-length cDNA coding for pepsinogen of rat gastric mucosa. Eur J Biochem 161:7-12.
75. International Union of Biochemistry and Molecular Biology. 1992. Enzyme nomenclature: Recommendations of the nomenclature committee of the International Union. San Diego, CA: Academic Press.
76. Jackman HL, Morris PW, Deddish PA, Skidgel RA, Erdos EG. 1992. Inactivation of endothelin I by deamidase (lysosomal protective protein). J Biol Chem 267:2872-2875.
77. James MNG, Sielecki AR. 1986. Molecular structure of an aspartic proteinase zymogen, porcine pepsinogen, at 1.8 Å resolution. Nature (London) 319: 33-38.
78. James MNG, Sielecki AR, Hayakawa K, Gelb MH. 1992. Crystallographic analysis of transition state mimics bound to pencillopepsin: Difluorstatine-and difluorostatone-containing peptides. Biochemistry 31:3872-3886.
79. Jia Z, Hasnain S, Hirama T, Lee X, Mort JS, To R, Huber CP. 1995. Crystal structure of rat cathepsin B and a cathepsin B-inhibitor complex: Implications for structure-based inhibitor design. J Biol Chem 270:5527-5533.
80. Kageyama T, Ichinose M, Tsukada S, Miki K, Kurokawa K, Koiwai O, Tanji M, Yakabe E, Athauda SBP, Takahashi K. 1992. Gastric procathepsin E and progastricsin from guinea pig. J Biol Chem 267:16450-16459.
81. Kageyama T, Takahashi K. 1986a. The complete amino acid sequence of monkey pepsinogen A. J Biol Chem 261:4395-4405.
82. Kageyama T, Takahashi K. 1986b. The complete amino acid sequence of monkey pepsinogen. J Biol Chem 261:4406-4419.
83. Kam CM, McCrae BJ, Harper JW, Niemann MA, Volanakis JE, Powers JC. 1987. Human complement proteins D, C2 and B. Active site mapping and peptide thioester substrates. J Biol Chem 262:3444-3451.
84. Kay J, Cassell B. 1971. The autoactivation of trypsinogen. J Biol Chem 246:6661-6665.
85. Kerfelec B, Chapus C, Puigserver A. 1985. Existence of ternary complexes of procarboxypeptidase A in the pancrease of some ruminant species. Eur J Biochem 151:515-519.
86. Kerr MA, Walsh KA, Neurath H. 1975. Catalysis by serine proteases and their zymogens. A study of acyl intermediates hy circular dichroism. Biochemistry 14:5088-5094.
87. Kerr MA, Walsh KA, Neurath H. 1976. A proposal for the mechanism of chymotrypsinogen activation. Biochemistry 15:5566-5570.
88. Khan AR, Cherney MM, Tarasova NI, James MNG. 1997. Structural characterization of activation intermediate 2 on the pathway to human gastricsin. Nature Struct Biol 4:1010-1015.
89. Kim H, Lipscomb WN. 1991. Comparison of the structures of three carboxypeptidase A-phosphonate complexes determined by X-ray crystallography. Biochemistry 30:8171-8180.
90. Kim S, Narayana SVL, Volanakis JE. 1994. Mutational analysis of the substrate binding site of human complement factor D. Biochemistry 33:14393-14399.
91. Kirschke H, Barrett AJ. 1987. Chemistry of lysosomal proteases. In: Glaumann H, Ballard AJ, eds. Lysosomes: Their role in protein breakdown. London, UK: Academic Press. pp 193-238.
92. Klionsky DJ, Banta LM, Emr SD. 1988. Intracellular sorting and processing of a yeast vacuolar hydrolase: Proteinase A propeptide contains vacuolar targetting information. Mol Cell Biol 8:2105-2116.
93. Koklitis PA, Murphy G, Sutton C, Angal S. 1991. Purification of recombinant human prostromelysin. Studies on heat activation to give high-Mr and low-Mr active forms, and a comparison of recombinant with natural stromelysin activities. Biochem J 276:217-221.
94. Kossiakotf AA, Chambers JL, Kay LM, Stroud RM. 1977. Structure of bovine trypsinogcn at 1.9 Å resolution. Biochemistry 16:654-664.
95. Kraut J. 1977. Serine proteases: Structure and mechanism of catalysis. Ann Rev Biochem 46:331-358.
96. Kunitz M. 1938. Formation of new crystallographic enzymes from chymotrypsin. J Gen Physiol 22:207-237.
97. Kunitz M, Northrop JH. 1935. Crystalline chymo-trypsin and chymo-trypsinogen. I. Isolation, crystallization, and general properties of a new proteolytic enzyme and its precursor. J Gen Physiol 18:433-456.
98. Lamba D, Bauer M, Huber R, Fischer S, Rudolph R, Kohnert U, Bode W. 1996. The 2.3 Å crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator. J Mol Biol 258:117-135.
99. Laskowski M Jr, Kato I. 1980. Protein inhibitors of proteinases. Ann Rev Biochem 49:593-626.
100. Liao DI, Breddam K, Sweet B, Bullock T, Remington SJ. 1992. Refined atomic model of wheat serine carboxypeptidase II at 2.2 Å resolution. Biochemistry 31:9796-9812.
101. Liszewski MK, Farries TC, Lublin DM, Rooney IA, Atkinson JD. 1996. Control of the complement system. Adv Immunology 61:201-283.
102. Madison EL, Kobe A, Gething M-J, Sambrook JF, Goldsmith EJ. 1993. Converting tissue plasminogen activator to a zymogen: A regulatory triad of Asp-Ser-His. Science 262:419-421.
103. Martzen MR, McMullen BA, Smith NE, Fujikawa K, Peanasky RJ. 1990. Primary structure of the major pepsin inhibitor from the intestinal parasitic nematode Ascaris suum. Biochemistry 29:7366-7372.
104. Mason RW, Massey SD. 1992. Surface activation of pro-cathepsin L. Biochem Bioph Res Commun 189:1659-1666.
105. Matthews BH. 1988. Structural basis of the action of thermolysin and related zinc peptidases. Acc Chem Res 21:333-340.
106. Matthews BW. 1977. In: Neurath H, Hill RL, eds. The proteins, 3rd ed. Vol. 3. New York: Academic Press. pp 404-590.
107. Matthews DA, Alden RA, Birktoft JJ, Freer ST, Kraut J. 1977. Re-examination of the charge-relay system in subtilisin and comparison with other serine proteases. J Biol Chem 252:8875-8883.
108. McIntyre GF, Godbold GD, Erickson AH. 1994. The pH-dependent membrane association of procathepsin L is mediated by a 9-residue sequence within the propeptide. J Biol Chem 269:567-572.
109. Merritt EA, Murphy MEP. 1994. Raster3D version 2.0: A program for photorealistic molecular graphics. Acta Crysallogr D50:869-873.
110. Miller M, Jaskolski M, Rao JKM, Leis J, Wlodawer A. 1989. Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature 337:576-579.
111. Moore SA, Sielecki AR, Chernaia MM, Tarasova NI, James MNG. 1995. Crystal and molecular structures of human progastricsin at 1.62 Å resolution. J Mol Biol 247:466-485.
112. Morgan PH, Walsh KA, Neurath H. 1974. Inactivation of trypsinogen by methane sulfonyl fluoride. FEBS Lett 41:108-110.
113. Muller-Eberhard HJ. 1988. Molecular organization and function of the complement system. Annu Rev Biochem 57:321-347.
114. Murphy GJP, Murphy G, Reynolds JJ. 1991. The origin of matrix metalloproteinases and their familial relationships. FEBS Lett 289:4-7.
115. Nagase H, Enghild JJ, Suzuki K, Salvesen G. 1990. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. Biochemistry 29:5783-5789.
116. Nagase H, Suzuki K, Enghild JJ, Salvesen G. 1991. Stepwise activation mechanisms of the precursors of matrix metalloproteinases I (tissue collagenase) and 3 (stromelysin). Biomed Biochim Acta 50:749-754.
117. Narayana SVL, Carson M, El-Kabbani O, Kilpatrick JM, Moore D, Chen X, Bugg CE, Volanakis JE, DeLucas LJ. 1994. Structure of human factor D. A complement system protein at 2.0 Å resolution. J Mol Biol 235:695-708.
118. Navia MA, Fitzgerald PMD, Mckeever BM, Leu C-T, Heimbach JC, Herber WK, Sigal IS, Darke PL, Springer JP. 1989. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. Nature 337:615-620.
119. Neurath H. 1957. The activation of zymogens. Adv Protein Chem 12:319-386.
120. Neurath H. 1959. Carboxypeptidases A and B. In: Boyer PD, Lardy H, Myrback K, eds. The enzymes, Vol. 4. New York: Academic Press. pp 11-37.
121. Neurath H. 1984. Evolution of proteolytic enzymes. Science 224:350-356.
122. Neurath H, Walsh KA. 1976. Role of proteolytic enzymes in biological regulation (a review). Proc Natl Acad Sci (USA) 73:3825-3832.
123. Okada Y, Harris ED Jr, Nagase H. 1988. The precursor of a metalloendopeptidase from human rheumatoid sinovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate. Biochem J 254:731-741.
124. Okada Y, Nakanashi I. 1989. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ("gelatinase") by human neutrophil elastase and cathepsin G. FEBS Lett 249:353-356.
125. Ollis DL, Cheah E, Cygler M, Dijkstra B, Frolow F, Franken SM, Harel M, Remington SJ, Silman I, Schrag J, Sussman JL, Verschueren KHG, Goldman A. 1992. The α/β hydrolase fold. Protein Eng 5:197-211.
126. Palmenberg AC. 1990. Proteolytic processing of picornaviral polyproteins. Ann Rev Microbiol 44:603-623.
127. Palmenberg AC, Rueckert RR. 1982. Evidence for intramolecular cleavage of picomaviral replicase processing enzyme. J Virol 41:244-249.
128. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773-785.
129. Pan D, Rubin GM. 1997. Kuzbanian controls proteolytic processing of Notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. Cell 90:271-280.
130. Pascual R, Vendrell J, Aviles FX, Bonicel J, Wicker C, Puigserver A. 1990. Autolysis of proproteinase E in bovine procarboxypeptidase A ternary complex gives rise to subunit III. FEBS Lett 277:37-41.
131. Perona JS, Craik CS. 1995. Structural basis of substrate specificity in the serine proleases. Protein Sci 4:337-360.
132. Peters JM. 1994. Proteasomes: Protein degradation machines of the cell. Trends Biochem Sci 19:377-382.
133. Pignol D, Granon S, Chapus S, Chapus C, Fontecilla-Camps JC. 1995. Crystallographic study of a cleaved, non-activatable form of porcine zymogen E. J Mol Biol 252:20-24.
134. Polgar L. 1989. Structure and function of serine proteases. In: Mechanisms of protease action. Boca Raton. Florida: CRC Press. Chapter 3.
135. Polgar L,. Halasz D. 1982. Current problems in mechanistic studies of serine and cysteine proteinases. Biochem J 207:1-10.
136. Potempa J, Korzus E, Travis J. 1994. The serpin superfamily of proteinase inhibitors: Structure, function, and regulation. J Biol Chem 269:15957-15960.
137. Puigserver A, Chapus C, Kerfelec B. 1986. In: Desnuelle P, Sjostrom H, Noren O, eds. Molecular and cellular basis of digestion. Amsterdam: Elsevier. pp 235-247.
138. Quiocho FA, Lipscomb WN. 1971. Carboxypeptidase A: A protein and an enzyme. Adv Protein Chem 25:1-78.
139. Rees DC, Lewis M, Lipscomb WN. 1983. Refined crystal .structure of carboxypeptidase A at 1.54 Å resolution. J Mol Biol 168:367-387.
140. Rees DC, Lipscomb WN. 1982. Refined crystal structure of potato inhibitor complex of carboxypeptidase A at 2.5 Å resolution. J Mol Biol 160:475-498.
141. Reinemer P, Grams F, Huber R, Kleine T, Schnierer S, Piper M, Tschesche H, Bode W. 1994. Structural implications for the role of the N-terminus in the superactivation of collagenases. FEBS Lett 338:227-233.
142. Renatus M, Engh RA, Stubbs MT, Huber R, Fischer S, Kuhnert U, Bode W. 1997. Lys156 promotes the anomalous proenzyme activity of t-PA: X-ray crystal structure of single-chain human t-PA. EMBO J 16:4797-4805.
143. Robertus JD, Kraut J, Alden RA, Birktoft JJ. 1972. Subtilisin: A stereochemical mechanism involving transition-state stabilization. Biochemistry 11:4293-4303.
144. Rovery M, Fahre C, Desnuelle P. 1953. Studies of the activation of bovine chymotrypsinogen and trypsinogen by determination of the N-terminal residues of the zymogens and their corresponding active enzymes (in French). Biochim Biophys Acta 12:547-559.
145. Rudenko G, Bonten E, d'Azzo A, Hol WGJ. 1995. Three-dimensional structure of the human "protective protein": Structure of the precursor form suggests a complex activation mechanism. Structure 15:1249-1259.
146. Ryan CA. 1989. Proteinase inhibitor gene families: Strategies for transformation to improve plant defenses against herbivores. Bioessays 10:20-24.
147. Schechter I, Berger A. 1967. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 27:157-162.
148. Seemuller E, Lupas A, Baumeister W. 1996. Autocatalytic activation of the 20S proteasome. Nature 382:468-470.
149. Sielecki AR, Hayakawa K, Fujinaga M, Murphy ME, Fraser M, Muir AK, Carilli CT, Lewicki JA, Baxter JD, James MNG. 1989. Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 Å resolution. Science 243:1346-1351.
150. Sogawa K, Fuji-Kuriyama Y, Mizukami Y, Ichihara Y, Takahashi K. 1983. Primary structure of human pepsinogen gene. J Biol Chem 258:5306-5311.
151. Sohl JL, Shiau AK. Rader SD, WilIk BJ, Agard DA. 1997. Inhibition of α-lytic protease by pro region C-terminal steric occlusion of the active site. Biochemistry 36:3894-3902.
152. Sprang S, Standing T, Fletterick RJ, Stroud RM, Finer-Moore J, Xuong NH, Hamlin R, Rutter WJ, Craik CS. 1987. The three-dimensional structure of Asn102 mutant of trypsin: Role of Asp102 in serine protease catalysis. Science 237:905-909.
153. Stein PE, Carrell RW. 1995. What do dysfunctional serpins tell us about molecular mobility and disease? Nature Struct Biol 2:96-113.
154. Steiner DF, Smeekens SP, Ohagi S, Chan SJ. 1992. The new enzymology of precursor processing endoproteases. J Biol Chem 267:23435-23438.
155. Steitz TA, Henderson R, Blow DM. 1969. Structure of crystalline α-chymotrypsin. 3. Crystallographic studies of substrates and inhibitors bound to the active site of α-chymotrypsin. J Mol Biol 46:337-348.
156. Steitz TA, Shulman RG. 1982. Crystallographic and NMR studies of the serine proteases. Ann Rev Bioph Bioeng 11:419-444.
157. Stevens RL, Qui D, McNeil HP, Friend DS, Hunt JE, Austen KF, Zhang J. 1996. Transgenic mice that possess a disrupted mast cell protease 5 (mMCP-5) gene cannot store carboxypeptidase A (mMC-CPA) protein in their granules. FASEB J 10:A1307.
158. Storer AC, Menard R. 1994. Catalytic mechanism in papain family of cysteine peptidases. Meth Enzymol 244:486-500.
159. Strausherg S, Alexander P, Wang L, Schwarz F, Bryan P. 1993. Catalysis of a protein folding reaction: Thermodynamic and kinetic analyses of subtilisin BPN' interactions with its propeptide fragment. Biochemistry 32:8112-8119.
160. Taggart RT, Cass LG, Mohandas TK, Derby P, Barr PJ, Pals G, Bell GI. 1989. Human pepsinogen C (progastricsin). Isolation of cDNA clones, localization to chromosome 6, and sequence homology with pepsinogen A. J Biol Chem 264:375-379.
161. Tanford C. 1997. How protein chemists learned about the hydrophobic factor. Protein Sci 6:1358-1366.
162. Tang J, James MNG, Hsu IN, Jenkins JA, Blundell TL. 1978. Structural evidence for gene duplication in the evolution of the acid proteases. Nature 271:618-621.
163. Tao K, Stearns NA, Dong J, Wu Q, Sahagian GG. 1994. The proregion of cathepsin L is required for proper folding, stability, and ER exit. Arch Biochem Biophys 311:19-27.
164. Tsukada H, Blow DM. 1985. Structure of α-chymotrypsin at 1.68 Å resolution. J Mol Biol 184:703-711.
165. Turk D, Podobnik M, Kuhelj R, Dolinar M, Turk V. 1996. Crystal structures of human procathepsin B at 3.2 Å and 3.3 Å resolution reveal an interaction molil between a papain-like cysteine protease and its propeptide. FEBS Lett 384:211-214.
166. Uren JR, Neurath H. 1972. Mechanism of activation of bovine procarboxypeptidase AS5. Alterations in primary and quaternary structure. Biochemistry 11:4483-4492.
167. Vallet V, Ahmed C, Gaeggler H-P, Horisberger J-D, Rossier BC. 1997. An epithelial serine protease activates the amiloride-sensitive sodium channel. Nature 389:607-610.
168. Valls LA, Winther JR, Stevens TH. 1990. Yeast carboxypeptidase Y vacuolar targetting signal is defined by four propeptide amino acids. J Cell Biol 111:361-368.
169. Vendrell J, Cuchillo CM, Aviles FX. 1990. The tryptic activation pathway of monomeric procarboxypeptidase A. J Biol Chem 256:6949-6953.
170. Vernet T, Berti PJ, de Montigny C, Musil R, Tessier DC, Menard R, Magny MC, Storer AC, Thomas DY. 1995. Processing of the papain precursor. The ionization of a conserved amino acid motif within the pro region participates in the regulation of intramolecular processing. J Biol Chem 270:10838-10846.
171. Vernet T, Khouri HE, Laflamme P, Tessier DC, Gour-Salin B, Storer AC, Thomas DY. 1991. Processing of the papain precursor. Purification of the zymogen and characterization of its mechanism of processing. J Biol Chem 266:21451-21457.
172. Volanakis JE, Narayana SVL. 1996. Complement factor D, a novel serine protease. Protein Sci 5:553-564.
173. Vu TKH, Liu RW, Haaksma CJ, Tomasek JJ, Howard EW. 1997. Identification and cloning of the membrane-associated serine protease, hepsin, from mouse pre-implantation embryos. J Biol Chem 272:31315-31320.
174. Wang D, Bode W, Huber R. 1985. Bovine chymotrypsinogen A. X-ray crystal structure analysis and refinement of a new crystal form at 1.8 Å resolution. J Mol Biol 185:595-624.
175. Weinmaster G. 1998. Reprolysins and astacins . . . Alive, Alive-O. Science 279:336-337.
176. Westphal V, Marcusson EG, Winther JR, Emr SD, van den Hazel HB. 1996. Multiple pathways for vacuolar sorting of yeast proteinase A. J Biol Chem 271:11865-11870.
177. White RT, Damm D, Hancock N, Rosen BS, Lowell BB, Usher P, Flier JS, Spiegelman BM. 1992. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem 267:9210-9213.
178. Wintersberger E, Cox DJ, Neurath H. 1962. Bovine pancreatic procarboxypeptidase B. I. Isolation, properties and activation. Biochemistry 1:1069-1078.
179. Winther JR, Sorenson P 1991. Propeptide of carboxypeptidase Y provides a chaperone-like function as well as inhibition of enzymatic activity. Proc Natl Acad Sci (USA) 88:9330-9334.
180. Wlodawer A, Erickson JW. 1993. Structure-based inhibitors of HIV-1 protease. Ann Rev Biochem 62:543-585.
181. Wright HT. 1996. The structural puzzle of how serpin serine proteinase inhibitors work. Bioessays 18:453-464.
182. Yamauchi Y, Stevens JW. Macon KJ, Volanakis JE. 1994. Recombinant and native zymogen forms of human complement factor D. J Immunol 152:3645-3653.